Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene expression profiling in sarcomas.

Katharina Tschoep1, Alexander Kohlmann, Marcus Schlemmer

  • 1Medizinische Klinik und Poliklinik III, Ludwig-Maximilians-University, Medical Center-Grosshadern, Munich, Germany. Katharina.Tschoep@med.uni-muenchen.de

Critical Reviews in Oncology/Hematology
|June 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes.

PloS one·2024
Same author

Pan-Tumor Analytical Validation and Osimertinib Clinical Validation in EGFR Mutant Non-Small-Cell Lung Cancer, Supporting the First Next-Generation Sequencing Liquid Biopsy in Vitro Diagnostic.

The Journal of molecular diagnostics : JMD·2023
Same author

Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib).

Clinical cancer research : an official journal of the American Association for Cancer Research·2022
Same author

A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce.

Scientific reports·2021
Same author

Olaparib for Metastatic Castration-Resistant Prostate Cancer.

The New England journal of medicine·2020
Same author

Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.

Blood·2020

Gene expression studies reveal novel biomarkers for sarcoma, improving classification and identifying potential therapeutic targets. These molecular insights offer new strategies for treating these challenging malignant mesenchymal tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Sarcomas are a diverse group of malignant mesenchymal tumors with poor prognoses and variable treatment responses.
  • A deeper understanding of sarcoma biology is crucial for developing new therapeutic targets and strategies.
  • Current classification methods face challenges due to the heterogeneity of sarcomas.

Purpose of the Study:

  • To review novel biomarkers identified through gene expression studies in sarcomas.
  • To explore how these biomarkers enhance understanding of sarcoma pathogenesis and classification.
  • To identify potential new therapeutic targets and predict treatment responsiveness.

Main Methods:

  • Comprehensive review of gene expression studies utilizing microarray analysis.

Related Experiment Videos

  • Analysis of identified gene expression patterns in various sarcoma subtypes.
  • Correlation of biomarker expression with tumor characteristics and clinical outcomes.

    • Main Results:

    • Gene expression profiling has identified new biomarkers offering insights into sarcoma pathogenesis.
    • Biomarkers allow for refined subclassifcation of tumors, such as calponin-positive and calponin-negative leiomyosarcoma.
    • Identified markers like ERBB2 and EGFR suggest potential therapeutic targets for synovial sarcoma.

    Conclusions:

    • Gene expression studies are vital for molecular characterization of sarcomas.
    • Novel biomarkers can improve sarcoma classification, predict prognosis, and guide treatment strategies.
    • Emerging molecular targets hold promise for the development of targeted therapies for sarcomas.